Stifel Maintains Hold on RxSight, Lowers Price Target to $7
RxSight, Inc.
RxSight, Inc. RXST | 0.00 |
Stifel analyst Tom Stephan maintains RxSight (NASDAQ:
RXST) with a Hold and lowers the price target from $8 to $7.
Stifel Maintains Hold on RxSight, Lowers Price Target to $7
RxSight, Inc. RXST | 0.00 |